Indian companies are starting the second half of fiscal year 2027 with resilient credit health, according to ICRA. While the credit ratio remains strong at 3.2 times, investors should watch for potential pressures from rising inflation, crude oil prices, and geopolitical trade risks.
Indian corporations are entering the second half of the 2027 fiscal year with stable credit profiles, according to the latest data from rating agency ICRA. The credit ratio, which measures the number of upgrades against downgrades, stands at 3.2 times. This indicates that companies are receiving more credit upgrades than downgrades, a performance level significantly higher than the 10-year historical average of 1.5 times. Furthermore, the annualised downgrade rate has reached a multi-year low of 4%, reflecting the strength of corporate balance sheets even as the broader economy faces volatility.
The power, real estate, auto components, and financial services sectors have been the primary drivers of this positive trend, accounting for roughly half of all rating upgrades. These sectors have benefited from consistent demand and improved operational stability, which has helped offset broader macroeconomic pressures. Despite this positive momentum, the overall economic outlook faces several challenges that may test corporate financial health in the coming months.
Macroeconomic headwinds include rising inflation and energy costs. Retail inflation is projected to average 5% for the current fiscal year, up from 2.1% in the previous year. To manage price and liquidity pressures, ICRA expects the central bank to hike the repo rate twice, by 25 basis points each, before the calendar year ends. Additionally, crude oil prices have reached $116 per barrel, which increases input costs for various industries. Another area of concern is rural consumption, which remains vulnerable due to erratic monsoon patterns. Reservoir levels are currently at 71% of capacity, a drop from 90% recorded a year ago, which could potentially impact agricultural output and overall rural income levels.
External factors also pose risks, particularly for export-oriented sectors. Geopolitical instability in West Asia has disrupted trade through the Strait of Hormuz, pushing up energy import costs. Furthermore, the Indian pharmaceutical industry faces specific trade risks. With 35% of Indian pharma exports currently directed to the United States, proposed changes to trade policies—including potential tariffs of up to 200% by 2029—create significant uncertainty for the sector. As a result of these combined internal and external factors, projected GDP growth for the full year has been revised to 7.1%, down from the 7.8% recorded in the first quarter.
For investors, the key monitorables will be how companies manage input cost inflation and whether the projected interest rate hikes impact borrowing costs and consumer demand. Tracking the performance of export-heavy sectors like pharmaceuticals, alongside rural demand indicators, will be essential to gauge the impact of current macroeconomic pressures on long-term corporate credit profiles.